X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3820) 3820
Book Chapter (24) 24
Magazine Article (16) 16
Web Resource (5) 5
Conference Proceeding (2) 2
Book / eBook (1) 1
Newsletter (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2586) 2586
pyoderma gangrenosum (1741) 1741
female (1328) 1328
dermatology (1209) 1209
male (1153) 1153
middle aged (859) 859
pyoderma gangrenosum - drug therapy (851) 851
adult (848) 848
pyoderma-gangrenosum (742) 742
pyoderma gangrenosum - diagnosis (717) 717
pyoderma gangrenosum - pathology (640) 640
pyoderma gangrenosum - etiology (525) 525
aged (516) 516
pyoderma (509) 509
diagnosis, differential (452) 452
pyoderma gangrenosum - complications (447) 447
treatment outcome (418) 418
surgery (332) 332
pyoderma gangrenosum - therapy (314) 314
immunosuppressive agents - therapeutic use (285) 285
infliximab (272) 272
medicine, general & internal (253) 253
skin (245) 245
therapy (232) 232
ulcerative colitis (226) 226
inflammatory bowel disease (219) 219
skin - pathology (218) 218
diagnosis (216) 216
skin diseases (216) 216
gastroenterology & hepatology (201) 201
adolescent (199) 199
care and treatment (188) 188
dermatology & venereal diseases (188) 188
disease (186) 186
ulcers (185) 185
case report (179) 179
biopsy (176) 176
anti-inflammatory agents - therapeutic use (173) 173
arthritis (170) 170
colitis, ulcerative - complications (168) 168
ulcerative-colitis (162) 162
management (155) 155
crohns-disease (153) 153
aged, 80 and over (151) 151
crohn's disease (145) 145
psoriasis (144) 144
crohn disease - complications (143) 143
wound healing (142) 142
patient (141) 141
young adult (141) 141
dermatologic agents - therapeutic use (139) 139
medicine & public health (135) 135
antibodies, monoclonal - therapeutic use (133) 133
child (131) 131
cyclosporine - therapeutic use (128) 128
inflammatory-bowel-disease (128) 128
neutrophilic dermatosis (128) 128
rheumatology (127) 127
glucocorticoids - therapeutic use (125) 125
drug therapy, combination (122) 122
acne (121) 121
cyclosporine (121) 121
vasculitis (119) 119
follow-up studies (117) 117
retrospective studies (114) 114
prednisolone - therapeutic use (111) 111
prednisone - therapeutic use (110) 110
recurrence (109) 109
adrenal cortex hormones - therapeutic use (108) 108
pyoderma gangrenosum - surgery (107) 107
abridged index medicus (106) 106
pediatrics (106) 106
sweets-syndrome (106) 106
anti-bacterial agents - therapeutic use (104) 104
inflammation (101) 101
extraintestinal manifestations (100) 100
inflammatory bowel diseases - complications (95) 95
risk factors (95) 95
skin diseases - drug therapy (94) 94
immunology (92) 92
internal medicine (90) 90
patients (90) 90
neutrophilic dermatoses (88) 88
hidradenitis suppurativa (87) 87
of-the-literature (87) 87
pyoderma gangrenosum - immunology (87) 87
case studies (85) 85
double-blind (85) 85
leukemia (85) 85
papa syndrome (84) 84
severity of illness index (84) 84
health aspects (83) 83
tacrolimus (81) 81
tumor necrosis factor-alpha - antagonists & inhibitors (80) 80
adalimumab (79) 79
combined modality therapy (79) 79
inflammatory bowel diseases (79) 79
syndrome (79) 79
pyoderma gangrenosum - epidemiology (78) 78
rheumatoid arthritis (78) 78
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3176) 3176
French (212) 212
German (178) 178
Spanish (126) 126
Korean (75) 75
Portuguese (47) 47
Japanese (31) 31
Polish (31) 31
Turkish (22) 22
Italian (18) 18
Czech (14) 14
Russian (13) 13
Danish (8) 8
Dutch (8) 8
Chinese (6) 6
Hungarian (6) 6
Croatian (3) 3
Finnish (2) 2
Norwegian (2) 2
Persian (2) 2
Serbian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 5, pp. 931 - 939
Background There are limited large case series of peristomal pyoderma gangrenosum (PPG), an uncommon cause of recalcitrant peristomal ulceration. Objective We... 
Dermatology | stoma | neutrophilic dermatosis | Crohn's disease | ulcer | pyoderma gangrenosum | inflammatory bowel disease | RISK-FACTORS | MANAGEMENT | CROHNS-DISEASE | ADALIMUMAB | USTEKINUMAB | RANDOMIZED CONTROLLED-TRIAL | DERMATOLOGY | INFLAMMATORY-BOWEL-DISEASE | THERAPY | TACROLIMUS | MYCOPHENOLATE-MOFETIL | Pyoderma Gangrenosum - drug therapy | Recurrence | Postoperative Complications - etiology | Humans | Middle Aged | Pyoderma Gangrenosum - surgery | Male | Skin Ulcer - etiology | Adrenal Cortex Hormones - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Diagnostic Errors | Aged, 80 and over | Adult | Biological Products - adverse effects | Female | Pyoderma Gangrenosum - diagnosis | Retrospective Studies | Postoperative Complications - drug therapy | Drug Therapy, Combination | Biological Products - therapeutic use | Pyoderma Gangrenosum - epidemiology | Reoperation | Disease Susceptibility | Risk Factors | Skin Ulcer - epidemiology | Postoperative Complications - surgery | Surgical Stomas - adverse effects | Postoperative Complications - epidemiology | Immunoglobulins, Intravenous - therapeutic use | Skin Ulcer - drug therapy | Pyoderma Gangrenosum - etiology | Adolescent | Inflammatory Bowel Diseases - surgery | Immunosuppressive Agents - adverse effects | Aged | Immunocompromised Host | Pyoderma | Care and treatment | Patient outcomes | Gastrointestinal diseases | Immunosuppressive agents
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, p. e0210436
Background/Aims Extraintestinal cutaneous manifestations of IBD represent a severe disease complication and an early and accurate treatment might positively... 
EXTRAINTESTINAL MANIFESTATIONS | SMOKING-CESSATION | DIAGNOSIS | CROHNS-DISEASE | MULTIDISCIPLINARY SCIENCES | ULCERATIVE-COLITIS | PYODERMA-GANGRENOSUM | ERYTHEMA-NODOSUM | COMPLICATIONS | CLINICAL-COURSE | Multivariate Analysis | Pyoderma Gangrenosum - drug therapy | Age Factors | Humans | Middle Aged | Child, Preschool | Male | Erythema Nodosum - drug therapy | Crohn Disease - complications | Young Adult | Aged, 80 and over | Adult | Female | Pyoderma Gangrenosum - diagnosis | Erythema Nodosum - diagnosis | Child | Colitis, Ulcerative - complications | Risk Factors | Erythema Nodosum - etiology | Switzerland | Pyoderma Gangrenosum - etiology | Adolescent | Sex Factors | Aged | Cohort Studies | Complications and side effects | Inflammatory bowel diseases | Usage | Skin diseases | Diagnosis | Medical screening | Risk factors | Therapy | Multivariate analysis | Epidemiology | Smoking cessation | Intestine | Hepatology | Gastroenterology | Questionnaires | Genetics | Physiology | Colon | Erythema nodosum | Immunomodulators | Age | Complications | Immunomodulation | Medical treatment | Patients | Crohns disease | Inflammatory bowel disease | Hospitals | Antibiotics | Pyoderma | Tumor necrosis factor | Ulcers | Histocompatibility antigen HLA | Erythema | Females | Steroid hormones | Steroids | Smoking | Ulcerative colitis | Pyoderma gangrenosum
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 73, Issue 4, pp. 615 - 622
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2018, Volume 77, Issue 12, pp. 1825 - 1833
Journal Article
Anais brasileiros de dermatología, ISSN 0365-0596, 2019, Volume 94, Issue 6, pp. 729 - 743
Journal Article
Orphanet journal of rare diseases, ISSN 1750-1172, 2013, Volume 8, Issue 1, pp. 136 - 136
Journal Article
Clinical and experimental immunology, ISSN 0009-9104, 2010, Volume 162, Issue 1, pp. 100 - 107
Summary Pyoderma gangrenosum (PG) is a rare, immune‐mediated inflammatory skin disease presenting with painful ulcers having undermined edges. Less commonly,... 
cytokines | pyoderma gangrenosum | matrix metalloproteinases | neutrophilic dermatoses | Sweet's syndrome | INTERLEUKIN-17 | PYODERMA-GANGRENOSUM | SWEETS-SYNDROME | NECROSIS-FACTOR-ALPHA | IMMUNOLOGY | EXPRESSION | Immunohistochemistry | Tumor Necrosis Factor-alpha - metabolism | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - metabolism | Antigens, CD - metabolism | Young Adult | Matrix Metalloproteinase 9 - metabolism | Sweet Syndrome - metabolism | Inflammation Mediators - metabolism | Adult | Female | Interleukin-8 - metabolism | Neutrophils - metabolism | Neutrophils - pathology | Pyoderma Gangrenosum - metabolism | Cytokines - metabolism | Matrix Metalloproteinase 2 - metabolism | Receptors, Cell Surface - metabolism | Sweet Syndrome - pathology | CD3 Complex - metabolism | Pyoderma Gangrenosum - pathology | Interleukin-17 - metabolism | Antigens, Differentiation, Myelomonocytic - metabolism | Adolescent | Aged | Matrix Metalloproteinases - metabolism | Peroxidase - metabolism | Skin diseases | Cytokines | T cells | Macrophages | Vascular endothelial growth factor | Wounds | CD3 antigen | Inflammation | Leukocytes (neutrophilic) | Lymphocytes T | Matrix metalloproteinase | Gelatinase B | Inflammatory diseases | Interleukin 17 | Gelatinase A | CD163 antigen | Ulcers | Peroxidase | Immunoreactivity | Chemokines | Interleukin 8 | Tumor necrosis factor- alpha | Translational Studies
Journal Article